Form 4: Conmed Corp Director David M. Bronson Reports Transactions

Director David M. Bronson reports transactions involving Conmed Corp stock, including the acquisition of shares through restricted stock units and options.

Summary

• On May 31, 2024, Director David M. Bronson acquired 302 shares of Conmed Corp common stock at $0 through the vesting of restricted stock units.
• Following this transaction, Bronson directly owns 16,762 shares of Conmed Corp common stock.
• On June 3, 2024, Bronson acquired 5,503 options to purchase common stock at a price of $77.18, exercisable from June 3, 2025, and expiring on June 3, 2034.
• Additionally, on June 3, 2024, Bronson acquired 479 restricted stock units, vesting from June 3, 2025, and expiring on June 3, 2034.
• After these transactions, Bronson directly owns 5,503 options and 479 restricted stock units.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document is a standard SEC filing reporting transactions by a company director. It doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of shares and options by a director could be interpreted as a positive signal regarding their confidence in the company's future prospects.

Future Outlook

The restricted stock units and stock options vest over time, aligning the director's interests with the long-term performance of the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• The transactions may influence investor perception of the company's stock.

Key Dates